Uncategorized Morgan Stanley Views Doximity (DOCS) Underperformance as Attractive Entry Point Amid Strong Engagement Post Content
Uncategorized Citizens Downgrades Life360 (LIF) to Market Perform Citing Skepticism Over 2026 Growth Catalysts Post Content
Uncategorized RBC Capital Predicts Growth for AI-Ready Software Firms Like Figma (FIG) as Enterprise Spending Stabilizes Post Content
Uncategorized BMO Capital Maintains Positive Long-Term Outlook for Vital Farms (VITL) Despite Temporary 2025 Revision Post Content
Uncategorized BofA Maintains Underperform Rating on GoodRx (GDRX) While Trimming PT to $2.60 Post Content
Uncategorized Roth Capital Notes Unexpected Cancellation of ReNew Energy (RNW) Take-Private Deal Following Masdar Withdrawal Post Content
Uncategorized Freedom Capital Highlights Gambling.com (GAMB) as Capital-Light Opportunity to Leverage US Market Legalization Post Content